Herliawati, Putu Arik, Dhian Eka Putri Harnandari, Rezha Alivia Hildayanti, Arghya Wicaksana, and Pande Putu Firsta. 2023. “Malignancy Risk Index 4 (RMI 4) Is Better Than RMI 3 As a Predictor Advanced Epithelial Ovarian Carcinoma Was Used for NACT”. Jurnal Ners 7 (1):536-42. https://doi.org/10.31004/jn.v7i1.13495.